Accent Microcell (NSE:ACCENTMIC) Change In Receivables : ₹-248 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Accent Microcell Change In Receivables?

Accent Microcell's change in receivables for the quarter that ended in Mar. 2024 was ₹-248 Mil. It means Accent Microcell's Accounts Receivable increased by ₹248 Mil from Mar. 2023 to Mar. 2024 .

Accent Microcell's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-248 Mil. It means Accent Microcell's Accounts Receivable increased by ₹248 Mil from Mar. 2023 to Mar. 2024 .

Accent Microcell's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹538 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Accent Microcell's Days Sales Outstanding for the six months ended in Mar. 2024 was 40.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Accent Microcell's liquidation value for the six months ended in Mar. 2024 was ₹882 Mil.

Accent Microcell Change In Receivables Historical Data

The historical data trend for Accent Microcell's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accent Microcell Change In Receivables Chart

Accent Microcell Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Change In Receivables

76.48

-47.53

-13.32

-248.29

Accent Microcell Semi-Annual Data
	Mar21	Mar22	Mar23	Mar24
Change In Receivables	76.48	-47.53	-13.32	-248.29

Accent Microcell Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-248 Mil.

Accent Microcell (NSE:ACCENTMIC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accent Microcell's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	538.042	/	2454.978	*	91
=	40.00

2. In Ben Graham's calculation of liquidation value, Accent Microcell's accounts receivable are only considered to be worth 75% of book value:

Accent Microcell's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	723.44	-	410.057	+	0.75 * 538.042	+	0.5 * 329.832
=	882

Accent Microcell Change In Receivables Related Terms

Thank you for viewing the detailed overview of Accent Microcell's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Accent Microcell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015

Website

https://www.accentmicrocell.com

Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.

Accent Microcell Headlines

No Headlines